Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest International Society for Biological Therapy of Cancer Stories

2013-06-14 23:01:56

Published in the Journal for ImmunoTherapy of Cancer, review offers recommendations for manufacturing, pre-clinical studies, and clinical trial designs of cancer immunotherapies Milwaukee, WI (PRWEB) June 14, 2013 A picture of what the FDA is looking for in cancer immunotherapy product development appears in an extensive review article published in the inaugural issue of the Journal for ImmunoTherapy of Cancer. This review outlines a series of recommendations from the FDA, including cited...

2013-05-30 23:14:29

FDA Review in SITC's Journal for ImmunoTherapy of Cancer offers new insights into cancer immunotherapy product development & clinical evaluation. Milwaukee, WI (PRWEB) May 30, 2013 A picture of what the FDA is looking for in cancer immunotherapy product development appears in an extensive new review article published in the inaugural issue of the Journal for ImmunoTherapy of Cancer. Providing a US regulatory perspective on pre-clinical to first in man studies, the review is described...

2008-10-30 12:00:21

Biothera will present the results of two separate Phase I clinical trials evaluating the safety of Imprime PGG(R), the company's developmental immunotherapy cancer drug, at the International Society for Biological Therapy of Cancer on Saturday, November 1 in San Diego, Calif. Biothera has completed two randomized, double-blind, placebo-controlled clinical studies in a total of 36 healthy volunteers. In the first Phase I study, subjects received a single intravenous infusion of placebo or...